Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...

Breast cancer has long been a significant health concern for women, but recent trends show an unsettling increase in ...

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...

Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.

Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...

A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...

Low-dose oral minoxidil, the hair growth drug which is the active ingredient in Rogaine, may be safe and effective for ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...